New Four-Drug attack on Fast-Spreading lung cancer
Disease control
Recruiting now
This study is testing if adding a drug called bevacizumab to a standard three-drug treatment can better control an aggressive type of lung cancer that has spread to the liver. It will involve 39 adults with extensive-stage small cell lung cancer who have not had prior treatment. …
Phase: PHASE2 • Sponsor: Kamya Sankar • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC